ThinkSabio

$ARGX

$875.06▲ -2.0% YTD

9 SEC 13D/G filings tracked · Last updated Nov 3, 2026

Filing History
News
ARGX ▼ -2.0% - argenx SE
CP $875.06▲ -2.0%Nov 3, 2026 · ThinkSabio Blog

$ARGX - argenx to Present at Upcoming Investor Conferences…

News
ARGX ▼ -0.4% - argenx SE
CP $815.99▲ -0.4%Oct 19, 2026 · ThinkSabio Blog

$ARGX - argenx to Present Phase 3 ALKIVIA Results in Autoimmune Myositis as a Late-Breaking Oral Presentation at ACR Convergence 2026…

News
ARGX ▼ -0.2% - argenx SE
CP $928.44▲ -0.2%Oct 8, 2026 · ThinkSabio Blog

$ARGX - argenx Provides Update on Phase 3 UNITY Study of Efgartigimod SC in Sjögren's Disease…

News
ARGX ▼ -0.2% - argenx SE
CP $928.44▲ -0.2%Oct 8, 2026 · ThinkSabio Blog

$ARGX - argenx Announces Positive Topline Results from Phase 2 Study of FB102 in Celiac Disease…

News
ARGX ▼ -0.1% - argenx SE
CP $971.30▲ -0.1%Sep 29, 2026 · ThinkSabio Blog

$ARGX - argenx Presents New Data at AANEM and MGFA Scientific Session Showcasing Earlier and Sustained Treatment in MG and CIDP with VYVGART and Progr…

News
ARGX ▲ +1.1% - argenx SE
CP $995.77▲ +1.1%Sep 17, 2026 · ThinkSabio Blog

$ARGX - argenx announces results of Extraordinary General Meeting of Shareholders and appointment of Thomas M. Brakel and Khurem Farooq as Non-Executi…

News
ARGX ▲ +0.8% - argenx SE
CP $1031.66▲ +0.8%Sep 1, 2026 · ThinkSabio Blog

$ARGX - argenx to Present at Upcoming Investor Conferences…

News
ARGX ▲ +0.9% - argenx SE
CP 1056.99▲ +0.9%Aug 27, 2026 · ThinkSabio Blog

$ARGX - argenx Completes Acquisition of Forte Biosciences, Inc…

SEC 13D/G
ARGX - argenx SE - SEC Filing Update (14-AUG-2026) | ThinkSabio - Stocks Simplified
$839.93▼ -0.04%Aug 14, 2026 · ThinkSabio Blog

$ARGX SEC 13D/G institutional ownership filing. Healthcare sector. SEC Filing Update: #ARGX argenx SE : $839.93 Sector: Healthcare | YTD: 🔽 -0.04% The…